Takethesis
4 known investors
Thesis develops nootropic supplement formulas—including blends for focus, motivation, stress, and memory—that target neurotransmitters and hormones tied to cognitive function. The company sells these personalized formulas directly to consumers on a subscription basis.
ConsumerDirect to ConsumerWellness & Fitness
Investors · 4
Frequently asked questions
- What does Takethesis do?
- Thesis develops nootropic supplement formulas—including blends for focus, motivation, stress, and memory—that target neurotransmitters and hormones tied to cognitive function. The company sells these personalized formulas directly to consumers on a subscription basis.
- Who are Takethesis's investors?
- Takethesis's investors include Evolution VC Partners, REDO Ventures, ECP Growth, Trust Ventures.
